Multiomics Profiling Reveals Distinct Immunosuppression and Metabolic Dysregulation in Aggressive Subtypes of Thyroid Cancer
Molecular & Cellular Proteomics · 2026-03 · 25 (3) · 101513
DOI: 10.1016/j.mcpro.2026.101513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2026-03. Verfasst von Shanying Gui und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic, Thyroid Cancer, Papillary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Medical Sciences, National Natural Science Foundation of China, Zhejiang Province Natural Science Foundation.
Abstract (Originalsprache)
Thyroid cancer comprises a heterogeneous group of malignancies with distinct clinical outcomes and molecular features, including papillary thyroid carcinoma (PTC), poorly differentiated thyroid carcinoma (PDTC), and anaplastic thyroid carcinoma (ATC). This study aimed to delineate the molecular and immune landscapes of these subtypes and identify potential biomarkers for the aggressive forms, ATC and PDTC. We assembled a well-annotated cohort of 120 formalin-fixed paraffin-embedded samples, including 35 ATC, 18 PDTC, 37 PTC cases, and 30 adjacent normal tissues (N) paired with PTC, collected over the past decade from multiple hospitals. To our knowledge, this represents the largest clinical ATC/PDTC cohort subjected to multiomics profiling and the first comprehensive proteomic analysis of these aggressive thyroid cancers. Using 4D-data-independent acquisition proteomics on 118 tumors (ATC 34, PDTC 18, PTC 36, and N 30), integrated with total RNA-seq on 69 samples (ATC 10, PDTC 5, PTC 31, and N 23), we revealed substantial molecular similarities between ATC and PDTC, both markedly distinct from PTC and adjacent normal tissues. ATC and PDTC exhibited significant enrichment in immune-related and metabolic pathways, with transcriptomic data indicating aggressive phenotypes and pronounced immunosuppression. Distinct immune landscapes of ATC and PDTC were revealed with neutrophil extracellular trap formation and M0 macrophage accumulation as key immunosuppressive mechanisms. Notably, Fc fragment of IgG receptor IIa (CD32) was identified as a promising biomarker for ATC, implicating a functional link between immune evasion and tumor aggressiveness. Our findings provide a comprehensive molecular and immunological characterization of thyroid cancer subtypes, offering novel insights into the pathogenesis of ATC and PDTC, and identifying potential targets for diagnosis and precision therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, China.
- Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Biomedical Sciences Laboratory, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China.
- Cancer Center, Department of Pathology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
- Department of Pathology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang, China.
- Department of Pathology, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, Zhejiang, China.
Förderung
- Chinese Academy of Medical Sciences
- National Natural Science Foundation of China
- Zhejiang Province Natural Science Foundation
Zitieren
APA
Gui, S., Huang, K., Qiang, J., Chen, Y., Gan, M., Jiang, Z., Qian, J., Yi, C., Ding, Y., Jiang, H., Zheng, F., Lei, W., Jin, L., Zhang, X., Fang, H., & Wang, M. (2026). Multiomics Profiling Reveals Distinct Immunosuppression and Metabolic Dysregulation in Aggressive Subtypes of Thyroid Cancer. Molecular & Cellular Proteomics, 25(3), 101513. https://doi.org/10.1016/j.mcpro.2026.101513
Vancouver
Gui S, Huang K, Qiang J, Chen Y, Gan M, Jiang Z, et al. Multiomics Profiling Reveals Distinct Immunosuppression and Metabolic Dysregulation in Aggressive Subtypes of Thyroid Cancer. Molecular & Cellular Proteomics. 2026;25(3):101513. doi:10.1016/j.mcpro.2026.101513
BibTeX
@article{Gui2026,
author = {Gui, Shanying and Huang, Kate and Qiang, Jianling and Chen, Yunzhao and Gan, Meifu and Jiang, Zhaochang and Qian, Jiazi and Yi, Chenchen and Ding, Yi and Jiang, Huihui and Zheng, Fulong and Lei, Wanlin and Jin, Lulu and Zhang, Xiaowei and Fang, Hezhi and Wang, Maofeng},
title = {Multiomics Profiling Reveals Distinct Immunosuppression and Metabolic Dysregulation in Aggressive Subtypes of Thyroid Cancer},
journal = {Molecular & Cellular Proteomics},
year = {2026},
volume = {25},
number = {3},
pages = {101513},
doi = {10.1016/j.mcpro.2026.101513}
}
EUVIMED